CS
Therapeutic Areas
Artios Pharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| alnodesertib (ART0380) | Platinum-resistant ovarian cancer (and other solid tumors) | Phase 2 |
| ART6043 | gBRCA-mutated HER2-negative breast cancer (and other solid tumors) | Phase 1/2 |
| Drug | Indication | Phase |
|---|---|---|
| alnodesertib (ART0380) | Platinum-resistant ovarian cancer (and other solid tumors) | Phase 2 |
| ART6043 | gBRCA-mutated HER2-negative breast cancer (and other solid tumors) | Phase 1/2 |